-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It seems that the new coronary pneumonia and RSV are not serious enough, and the incidence of Lyme disease is also rising in the United States, including Oklahoma
Lyme disease affects approximately 300,000 people in the United States alone
Although early antibiotic treatment is effective for most patients, approximately 10-20% of patients continue to suffer symptoms that may include fatigue, muscle pain, and cognitive impairment for more than 6 months after treatment
"Cell" magazine will publish a paper entitled "Selective Antibiotics for Lyme Disease" in the October 2021 issue
OU researcher Helen I.
"Screening of soil microorganisms showed that a compound is highly selective for spirochetes, including Borrelia burgdorferi
Original search:
DOI
10.
Article title
A selective antibiotic for Lyme disease
